Promedicament (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Promedicament" in Romanian language version.

refsWebsite

Global rank Romanian rank

2^nd place

3^rd place

4^th place

234^th place

260^th place

5^th place

11^th place

doi.org

Rautio, Jarkko; Meanwell, Nicholas A.; Di, Li; Hageman, Michael J. (27 aprilie 2018). „The expanding role of prodrugs in contemporary drug design and development”. Nature Reviews Drug Discovery (în engleză). doi:10.1038/nrd.2018.46. ISSN 1474-1776.
Malhotra, B; Gandelman, K; Sachse, R; Wood, N; Michel, M. C. (2009). „The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine”. Curr. Med. Chem. 16 (33): 4481–9. doi:10.2174/092986709789712835. PMID 19835561.
Stella, VJ; Charman, WN; Naringrekar, VH (1985). „Prodrugs. Do they have advantages in clinical practice?”. Drugs. 29 (5): 455–73. doi:10.2165/00003495-198529050-00002. PMID 3891303.

Rautio, Jarkko; Meanwell, Nicholas A.; Di, Li; Hageman, Michael J. (27 aprilie 2018). „The expanding role of prodrugs in contemporary drug design and development”. Nature Reviews Drug Discovery (în engleză). doi:10.1038/nrd.2018.46. ISSN 1474-1776.

Malhotra, B; Gandelman, K; Sachse, R; Wood, N; Michel, M. C. (2009). „The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine”. Curr. Med. Chem. 16 (33): 4481–9. doi:10.2174/092986709789712835. PMID 19835561.
Stella, VJ; Charman, WN; Naringrekar, VH (1985). „Prodrugs. Do they have advantages in clinical practice?”. Drugs. 29 (5): 455–73. doi:10.2165/00003495-198529050-00002. PMID 3891303.

Rautio, Jarkko; Meanwell, Nicholas A.; Di, Li; Hageman, Michael J. (27 aprilie 2018). „The expanding role of prodrugs in contemporary drug design and development”. Nature Reviews Drug Discovery (în engleză). doi:10.1038/nrd.2018.46. ISSN 1474-1776.